Unknown EARLY_PHASE1 INTERVENTIONAL 2-arm NCT04230577

Photobiomodulation to Improve Cognition in TBI, With fMRI

Transcranial Photobiomodulation to Improve Cognition in TBI, With Pre-/Post- fMRI Scans: A Pilot, Sham-Controlled Study

Sponsor: Boston VA Research Institute, Inc.

Conditions Closed Head Injury Cognitive Dysfunction Traumatic Brain Injury

Interventions Real LED Intervention Sham LED Intervention

Updated 6 times since 2020 Last updated: Feb 24, 2022 Started: Aug 7, 2019 Primary completion: Mar 31, 2023 Completion: Sep 30, 2023

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A EARLY_PHASE1 clinical study on Closed Head Injury and Cognitive Dysfunction, this trial is ongoing. The trial is conducted by Boston VA Research Institute, Inc. and has accumulated 6 data snapshots since 2019. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Unknown EARLY_PHASE1
Jul 2024 — Sep 2024 [monthly]

Unknown EARLY_PHASE1

Status: Unknown Status → Unknown
Mar 2024 — Jul 2024 [monthly]

Unknown Status EARLY_PHASE1

Status: Recruiting → Unknown Status
Mar 2022 — Mar 2024 [monthly]

Recruiting EARLY_PHASE1
Jan 2021 — Mar 2022 [monthly]

Recruiting EARLY_PHASE1

▶ Show 1 earlier version

Feb 2020 — Jan 2021 [monthly]

Recruiting EARLY_PHASE1

First recorded

Aug 2019

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Boston VA Research Institute, Inc.
VA Boston Healthcare System
Vielight Inc.

Data source: Boston VA Research Institute, Inc.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Boston, United States